FDA-approved, but no longer sold in the US.
No perspectives yet — be the first!
Be the first verified clinician to share a view on Abarelix.
100% anonymous · NPI-verifiedFDA status last checked Nov 11, 2026
A synthetic decapeptide and antagonist of naturally occurring gonadotropin-releasing hormone (GnRH).
Abarelix
Approved by the FDA, but no longer sold in the US.
Only small or early studies in people so far.
No brand records are linked yet.
How it works. Proven facts and ideas still being studied are kept apart.
Not yet reviewed.
Only small or early studies in people so far.
FDA-approved, but no longer sold in the US (all US products discontinued). Applications: NDA021320.
Last verified: Nov 11, 2026
Share your perspective on Abarelix and help peers make informed prescribing decisions.
Your 45-second perspective helps thousands of colleagues.
Your real-world insights guide colleagues
Your identity stays private — only specialty/region shown
Compare your perspective to specialty peers
